Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-24

Clinical Trial Update: Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Cerebrolysin as add-on therapy to mechanical thrombectomy in acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cerebrolysin

Snippet

Sponsor: Military Institute od Medicine National Research Institute | Conditions: Stroke, Ischemic, Stroke, Acute | Phase 3 | Status: UNKNOWN